20 (AIDX) Return on Equity (2026)
20 posted quarterly Return on Equity of 0.02% for Q1 2026.
20 (AIDX) has 1 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.
- For the quarter ending Q1 2026, Return on Equity changed N/A year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (changed N/A YoY), and the FY2025 full-year result was 0.05%, changed N/A from the prior year.
- Return on Equity for Q1 2026 stood at 0.02%.
- Across five years, Return on Equity topped out at 0.02% in Q1 2026 and bottomed at 0.02% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | 20 | - | - | 62,884.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |